Presentation TCT 2012 Bioabsorbable Stent Components and Stents Presenter: Shigeru Saito October 24, 2012
Presentation TCT 2012 Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents) Presenter: John Ormiston October 24, 2012
Presentation TCT 2012 "Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting... Presenter: Hyeon-Cheol Gwon October 24, 2012
News Conference News TCT 2012 Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents October 24, 2012
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
Presentation TCT 2012 MASTER: A Prospective, Randomized Trial of a PET Micronet Mesh-Covered Stent vs. Standard Stents in Patients with ST-Segment Elevation Myocardial Infarction Presenter: Gregg Stone October 24, 2012
News Conference News TCT 2012 ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD October 24, 2012
News Conference News TCT 2012 Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology October 24, 2012
Presentation TCT 2012 A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions Presenter: Thomas Zeller October 24, 2012
Presentation TCT 2012 TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up Presenter: Josep Gomez-Lara October 23, 2012
Presentation TCT 2012 TCT-51. Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-eluting Stents: Insight from the Florence Left Main-PCI... Presenter: Renato Valenti October 23, 2012
Presentation TCT 2012 TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting... Presenter: Clemens von Birgelen October 23, 2012
Presentation TCT 2012 TCT-46. Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-in-man Trial Presenter: Eberhard Grube October 23, 2012
Presentation TCT 2012 TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable... Presenter: Patrick Serruys October 23, 2012
Presentation TCT 2012 Nanoparticle-Based Stents 2: FOCUS np (Envision Scientific) Program Update Presenter: Ashok Seth October 23, 2012
Presentation TCT 2012 Nanoparticle-Based Stents 1: Mitsui (Meril Life Sciences) Program Update Presenter: Ricardo Costa October 23, 2012
Presentation TCT 2012 Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety Presenter: Ajay Kirtane October 23, 2012
Presentation TCT 2012 Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice Presenter: Tony Das October 23, 2012
Presentation TCT 2012 Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results Presenter: Michael Haude October 23, 2012